Cyclerion Therapeutics (CYCN) Receivables - Net (2021 - 2025)

Cyclerion Therapeutics' Receivables - Net history runs 5 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• In Q4 2025, Receivables - Net rose 79.86% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 79.86% YoY), while the FY2025 annual figure was $1.0 million, up 79.86% from the prior year.
• Receivables - Net was $1.0 million for Q4 2025 at Cyclerion Therapeutics, up from $100000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.0 million in Q4 2025 to a low of $44000.0 in Q3 2024.
• Historically, Receivables - Net has averaged $302846.2 across 5 years, with a median of $227000.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Receivables - Net plunged 57.71% in 2023, then surged 127.27% in 2025.
• A 5-year view of Receivables - Net shows it stood at $100000.0 in 2021, then retreated by 4.0% to $96000.0 in 2022, then changed by 0.0% to $96000.0 in 2023, then soared by 479.17% to $556000.0 in 2024, then jumped by 79.86% to $1.0 million in 2025.
• The last three Receivables - Net figures came in at $1.0 million (Q4 2025), $100000.0 (Q3 2025), and $525000.0 (Q2 2025), per Business Quant data.